Alphatec had the best second quarter, with a 35 percent increase in revenue, while Conformis, which saw its revenue fall 73 percent compared to last year, had the worst.
14 orthopedic and spine company revenues for Q2:
1. ZimVie: $233.4 million
2. Surgalign: $20.6 million
3. Conformis: $15.3 million
4. Alphatec: $84 million
5. Orthofix: $118.1 million
6. Enovis: $395 million
7. Paragon: $36.8 million
8. NuVasive: $310.5 million
9. SeaSpine: $56.3 million
10. Zimmer Biomet: $1.8 billion
11. Smith + Nephew: $1.3 billion
12. Stryker: $4.5 billion
13. Johnson & Johnson: $2.2 billion
14. Implanet: $2.1 million
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
